Literature DB >> 15942996

The Childhood Cancer Survivor Study: a resource for research of long-term outcomes among adult survivors of childhood cancer.

Leslie L Robison1.   

Abstract

Improvements in the treatment of the cancers occurring among children and adolescents have resulted in a large number of patients achieving long-term survival. Treatment-related factors have been shown to have an impact on subsequent health status and quality of life, although there are limited data on survivors who are now 2 or more decades past treatment. The Childhood Cancer Survivor Study (CCSS) was established as a resource for investigating the long-term outcomes of a cohort of 5-year survivors of pediatric and adolescent cancer, who were diagnosed between 1970 and 1986. The CCSS consists of more than 14,000 active participants, including survivors of leukemia, brain tumors, Hodgkin's disease, non-Hodgkin's lymphoma, Wilms' tumor, neuroblastoma, soft-tissue sarcoma, and bone tumors, who have provided self-reported sociodemographicand health-related information. The survivor population has been found to be at increased risk of a broad spectrum of adverse outcomes, such as late mortality, second cancers, pulmonary complications, pregnancy loss, giving birth to offspring with low birth weights, and decreased educational attainment. The ongoing evaluation of large and diverse cohorts of cancer survivors, through resources such as the CCSS, will aid in further identifying high-risk individuals who should be the target of innovative intervention strategies.

Entities:  

Mesh:

Year:  2005        PMID: 15942996

Source DB:  PubMed          Journal:  Minn Med        ISSN: 0026-556X


  17 in total

Review 1.  Wilms tumor--a renal stem cell malignancy?

Authors:  Naomi Pode-Shakked; Benjamin Dekel
Journal:  Pediatr Nephrol       Date:  2011-04-16       Impact factor: 3.714

2.  Physical and mental health status and health behaviors of childhood cancer survivors: findings from the 2009 BRFSS survey.

Authors:  Celeste R Phillips-Salimi; Karen Lommel; Michael A Andrykowski
Journal:  Pediatr Blood Cancer       Date:  2011-10-19       Impact factor: 3.167

3.  Fatigue, vitality, sleep, and neurocognitive functioning in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.

Authors:  Nancy R Clanton; James L Klosky; Chenghong Li; Neelam Jain; Deo Kumar Srivastava; Daniel Mulrooney; Lonnie Zeltzer; Marilyn Stovall; Leslie L Robison; Kevin R Krull
Journal:  Cancer       Date:  2011-04-11       Impact factor: 6.860

4.  Scarring, disfigurement, and quality of life in long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor study.

Authors:  Karen E Kinahan; Lisa K Sharp; Kristy Seidel; Wendy Leisenring; Aarati Didwania; Mario E Lacouture; Marilyn Stovall; Anand Haryani; Leslie L Robison; Kevin R Krull
Journal:  J Clin Oncol       Date:  2012-05-21       Impact factor: 44.544

5.  Health conditions and quality of life in survivors of childhood acute myeloid leukemia comparing post remission chemotherapy to BMT: a report from the children's oncology group.

Authors:  Kris Ann P Schultz; Lu Chen; Zhengjia Chen; Toana Kawashima; Kevin C Oeffinger; William G Woods; H Stacy Nicholson; Joseph P Neglia
Journal:  Pediatr Blood Cancer       Date:  2013-11-27       Impact factor: 3.167

6.  Aging in the context of cancer prevention and control : perspectives from behavioral medicine.

Authors:  Keith M Bellizzi; Karen M Mustian; Deborah J Bowen; Barbara Resnick; Suzanne M Miller
Journal:  Cancer       Date:  2008-12-15       Impact factor: 6.860

Review 7.  Cancer survivorship and aging : moving the science forward.

Authors:  Keith M Bellizzi; Karen M Mustian; Oxana G Palesh; Michael Diefenbach
Journal:  Cancer       Date:  2008-12-15       Impact factor: 6.860

Review 8.  Models of Cancer Survivorship Care for Adolescents and Young Adults.

Authors:  Karen E Kinahan; Stacy Sanford; Karim T Sadak; John M Salsman; Karina Danner-Koptik; Aarati Didwania
Journal:  Semin Oncol Nurs       Date:  2015-05-07       Impact factor: 2.315

9.  Risk of subsequent cancer following a primary CNS tumor.

Authors:  Kyle Strodtbeck; Andrew Sloan; Lisa Rogers; Paul Graham Fisher; Duncan Stearns; Laura Campbell; Jill Barnholtz-Sloan
Journal:  J Neurooncol       Date:  2013-02-08       Impact factor: 4.130

Review 10.  Targeted therapy aimed at cancer stem cells: Wilms' tumor as an example.

Authors:  Rachel Shukrun; Naomi Pode Shakked; Benjamin Dekel
Journal:  Pediatr Nephrol       Date:  2013-06-13       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.